← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Itherx Pharmaceuticals, Inc.
San Diego, CA
$1,200,223
Total funding
6
Grants
Funding over time
peak $153.2K · FY2008–09$200K$150K$100K$50K$0
'08
'09
Funding mix
By agency
NIH$1,200,223 · 6
By mechanism
R44$845,825 · 3
R43$354,398 · 3
Investigators at Itherx Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
HAIRPIN RIBOZYME GENE THERAPY FOR HCV INFECTION$318,276
R44 · FY2000 · AI
Chimeric Ribozyme for Treatment of PVR$301,237
R44 · FY2001 · EY
RIBOZYMES FOR THE PREVENTION OF RESTENOSIS AFTER PTCA$226,312
R44 · FY2000 · HL
Investigation of the Potential Anti-Diabetic Activity of ITX2158 In Vivo$153,155
R43 · FY2009 · DK
In vivo efficacy evaluation of pyrvinium analogs in non small cell lung (NSCL) ca$101,269
R43 · FY2008 · CA
IDENTIFICATION OF CELLULAR GENES FOR HCV GENE EXPRESSION$99,974
R43 · FY2000 · AI